ZANTAC 300 Glaxo (Zantac 300 300 mg)
Generic Name: ranitidine
Pill imprint ZANTAC 300 Glaxo has been identified as Zantac 300 300 mg.
Zantac 300 is used in the treatment of gerd; zollinger-ellison syndrome; erosive esophagitis; duodenal ulcer; stomach ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Zantac 300 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ranitidine
- Imprint:
- ZANTAC 300 Glaxo
- Strength:
- 300 mg
- Color:
- Yellow
- Size:
- 16.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0393
- Inactive Ingredients:
- croscarmellose sodium
D&C Yellow No. 10
hypromelloses
magnesium stearate
microcrystalline cellulose
titanium dioxide
triacetin
| NDC Code | Manufacturer / Repackager |
|---|---|
| 52959-0201 | H.J. Harkins Company, Inc (repackager) |
Note: Inactive ingredients may vary.
More about Zantac 300 (ranitidine)
Consumer resources
- Other brands: Taladine
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
